The central role of APP and PSs in the genesis of AD is unquestionable; however, phenotypical heterogeneity among patients, and even among familial patients with the same genetic mutation, is commonly observed, implying that other genes might have a role in regulating the onset and severity of the neurodegeneration in FAD and, likely, in sporadic AD. The gene discussed is APP; the disease is Alzheimer disease.